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A New 185,000-dalton Skeletal Muscle Protein
Detected by Monoclonal Antibodies
ABSTRACT
￿
The M line, which transverses the center of the thick filament region of skeletal
muscle sarcomeres, appears to be a complex array of multiple structural elements. To date,
two proteins have definitely been shown to be associated with the M line. They are MM-CK,
localized in the M 4,4' substriations, and a 165,000-dalton (164 kd) protein, referred to as
both M-protein and myomesin. Here we report the positive identification of a third Wine
protein of 185 kd . In the course of making monoclonal antibodies (mAbs) against a 165-kd
fraction, we also obtained mAbs that bound to the M line of isolated myofibrils as detected
by indirect immunofluorescence, but recognized a protein band of 185 kd in immunoblotting
experiments with either the original immunogen or low ionic strength myofibril extracts as
antigenic targets. The evidence that the 185- and 165-kd proteins are distinct protein species
is based on the separation of the two proteins into discrete peaks by ion exchange chroma-
tography, the distinctive patterns of their degradation products, and non-cross-reactivity of
any of seven mAbs. These mAbs recognize three unique antigenic determinants on the 185-
kd molecule and at least two and probably four sites on the 165-kd molecule as determined
from competitive binding and immunofluorescence experiments. To resolve the problem of
multiple nomenclature for the 165-kd protein, the 185-kd protein will be referred to as
myomesin and the 165-kd protein as M-protein .
Myofibrils, the organelles that form the contractile apparatus
of cross-striated muscle cells, show distinct structures perpen-
dicular to the thick and thin filaments. The Z-line structure
that defines single sarcomeres anchors thin filaments and
probably giant proteins such as titin (1) as well. Several
possible functions for the other prominent transverse struc-
ture, the M line, have been proposed (2-8). More and more
Z- and M-line protein components have been detected, iso-
lated, and characterized, which has revealed an ever increasing
complexity ofthese structures. The existence of at least three
structural elements has been postulated for the M-line region
(9), where high resolution electron microscopy reveals a min-
imal number of five transverse striations and a so called M
filament, which parallels the myosin filaments in the M region
(2, 10-13).
To date, two proteins have definitely been shown to be
associated with the M line; one is MM-CK (4, 14, 15) and the
other is a 165,000-dalton (165-kd) protein (3, 16-18). MM-
CK has been assigned to substriations M4 and M4' (19, 20),
while the sublocalization ofthe high molecular weight M-line
protein is still unclear. However, from several observations in
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our laboratory and in other laboratories as well, it has been
concluded that additional protein components must be lo-
cated within the M-line structure.
Although polyclonal antibodies made against a purified
165-kd M-line protein fraction specifically stained the M line
in immunocytological tests, depending on preparation and
extraction conditions of the antigen, multiple bands were
frequently apparent after gel electrophoresis (16, 18) and
subsequent immunoblotting (Doetschman, unpublished ob-
servations), thus suggesting additional M-line proteins. Indi-
cation for the existence of a potential M-line protein of 190
kd found in myofibril extracts had been reported earlier (21),
but an unambiguous assignmentas an M-line protein had not
been made.
Here we report the positive identification of a new 185-kd
M-line protein and the resolution ofthe high molecular weight
185- and 165-kd proteins as two independent M-line-specific
components by monoclonal antibodies (mAbs).'
'Abbreviations used in this paper.
￿
DTT, dithiothreitol; ELISA,
enzyme-linked immunosorbentassay; mAbs,monoclonal antibodies;
PMSF, phenylmethylsulfonyl fluoride.
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M-line Protein Purification
M-line proteins used for immunization were isolated from pectoralis muscle
ofadult chicken according to Trinick and Lowey (17) with the modifications
applied by Eppenberger and Strehler (22) . Additional modifications used in a
subsequentpurification(Fig . 4)are asfollows: (a) Buffer volumeswere increased
twofold . (b) The initial homogenization and wash buffer [0.1 M KCI, 1 mM
EGTA, 5 mM EDTA, I mM dithiothreitol (DTT), 0.1 mM phenylmethylsul-
fonyl fluoride (PMSF) (SERVA Feinbiochemica GmbH & Co ., Heidelberg,
West Germany), pH 7] contained 1 mM L-1-tosylamide-2-phenylethyl chloro-
methyl ketone (TPCK) (Sigma Chemical Co ., St. Louis, MO), 0 .5 mM N-p-
tosyl-L-lysine chloromethyl ketone (TLCK) (Sigma Chemical Co .), and 0.5%
Triton X-100 . Stock solutions of the protease inhibitors PMSF, TPCK, and
TLCK were dissolved in DMSO. (c) The saturated (NH4)2S04 solution used in
the 32% ammonium sulfate cut ofthe high salt extract contained I mM MgCl2
and 0 .3 mM EGTA; (d) After dialysis against 1 mM EDTA, 0.3 mM DTT, 10
mM potassium phosphate, pH 6.9, to precipitate actomyosin, ammonium
sulfate was added to the supernatant to give a concentration of 50% . The
redissolved pellet was dialyzed for 24 h instead of 48 h in three changes of
buffer. Aliquots of samples from each stage ofthe preparation were analyzed
for M-line protein content by 7% SDS PAGE followed by Coomassie Blue
staining or immunoblotting with mAbs.
Monoclonal Antibodies
BALB/c mice were immunized intraperitoneafly with 100 kg of alum-
precipitated, purified M-line protein fraction. 3 mo later they were boosted
with 100 kg of protein intravenously . After 3 d the spleen cells were isolated
and fused (23) with P3-NS1/lAg4-1 (NS-1) mouse myeloma cells, and clones
were grown in Dulbecco's modified Eagle's hypoxanthine/aminopterin/thy-
midine medium (24) containing 15% selected newborn calf serum. Selected
hybridomas were subcloned by limiting dilution .
Solid-phase Immunoassays
ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA): An ELISA
plate binding assay (25) was used for screening culture supernatants. PVC
microtiter plates (Costar, Cambridge, MA) were coated with 1 kg of antigen
per well . mAbs were added for 2 h, followed by peroxidase-conjugated rabbit
anti-mouse IgG (Nordic Immunological Laboratories, Tillburg, The Nether-
lands)for 1 h . Thebound enzyme wasindicated by the additionofthe substrates
o-phenylenediamine and H202, and the adsorbance was read at 490 nm with a
Microelisa Autoreader (Dynatech Laboratories Inc., Alexandria, VA). Back-
ground values between 0.02 and 0.04 A U obtained with NS-1 culture super-
natants as the primary antibody were subtracted from experimental values .
COMPETITIVE BINDING EXPERIMENTS:
￿
Radioactivelylabeled InAbs
were obtained by culturing the hybridomas in methionine-free hybridoma
medium containing 1% newborn calf serum and 10 ACi/ml f"S]methionine
(New England Nuclear, Boston, MA) for 30 h (26). "S-labeled mAbs were
separated from free ["S]methionine by G-25 column chromatography, and
18,000-20,000 dpm were added per well coated with l tag of target antigen in
the presence ofincreasing concentrations ofunlabeled mAb. Afterincubations
of 3 h or overnight, the bound radioactivity was solubilized in 100 tal of 2 N
NaOH and counted in 4 ml of scintillation fluid (Dimilume-30, Packard
InstrumentCo ., Downers Grove, IL). Background values in wells lacking target
antigen were ^-40 dpm/well .
Myofibril Preparation
Fiber bundles were prepared from chicken pectoralis major (l5), except that
the fiber bundles were kept in solution A (0.l M KCI, 1 mM EGTA, 5 mM
EDTA, l mM DTT, pH 7 .0) containing 50% (vol/vol) glycerol overnight at
4°C . After a change to fresh buffer, the fiber bundles were stored at -20°C.
Myofibrils were excised from fiber bundles and prepared according to
Kundrat and Pepe (27) with the precautions given by Heizmann et al . (28) .
Immunofluorescence
A drop ofmyofibrils was added to a glass coverslip in a 60-mm Petri dish
for l min, then washed one time quickly by flooding the dish with solution A
(-3 ml), followed by two 5-min washes in solution A. For SDS treatment,
myofibrils were fixed with 3% paraformaldehyde in solution A for 15 min and
washed with 0 .1 M glycine in solution A once quickly, twice for 5 min each,
and once for 15 min . Myofibrils were then exposed to 0. l % SDS in PBS for 2
min, washed three times for 5 min each in PBS followed by 1% Triton X-100
in PBS for l min, and again washed in PBS .
For immunofluorescence, 30 tul of mAbs as undiluted culture supernatants
were added for 30 min, washed 3 times for 5 min each in PBS followed by
rhodamine-conjugated sheep anti-mouse IgG (Cappel Laboratories Inc., Coch-
ranville, PA) (1 :500 in PBS) for 30 min, and again washed in PBS. All
procedures were carried out at room temperature. Coverslipswere mounted on
a glassslide in one dropof0 .1 M glycine, 50% glycerol, pH 9.0, for fluorescence
microscopy on a Zeiss microscope equipped with epiluminescence and a
rhodamine filter pack (Carl Zeiss, Oberkochen, West Germany) .
Immunoblotting after SDS PAGE
Sampleswere electrophoresed on 7% SDS polyacrylamide slab gels with 3%
stacking gels (29), and the proteins were electrophoretically transferred to
nitrocellulose membranes (30) . After blocking nonspecific binding sites with
PBS containing 10% fetalcalfserum,thenitrocellulose membranes were reacted
sequentially with mAbs (undiluted culture supernatants) overnight on a shaker
at room temperature and with peroxidase conjugated rabbit anti-mouse IgG
(1:300 in PBS with 10% serum) for 4 h also on a shaker at room temperature .
After each incubation, nitrocellulose membranes were washed for ^-30 min in
three changes of PBS plus 10% serum. Color development was obtained with
a 1 :10 dilution of chloronapthol stock solution (3 mg/ml methanol) in PBS
plus I )AI/ml 30% H202 and stopped by a 5-min wash in H2O . Proteins were
visualized in duplicate gels by silver stain (Bio-Rad Laboratories, Richmond,
CA).
RESULTS
mAbs were generated to more precisely localize and charac-
terize the 165-kd M-line protein . BALB/c mice were immu-
nized with a 165-kd protein fraction purified from chicken
pectoralis major (see Materials and Methods) and the spleen
cells were fused with NS-1 mouse myeloma cells . After initial
selection by ELISA screening using the immunogen as the
target antigen, seven mAbs were obtained that specifically
bound to the M-line of isolated chicken myofibrils as dem-
onstrated by indirect immunofluorescence. Four ofthe mAbs,
B5 (Fig. 1 a), A2, B4, and C2, bound readily to theM line of
native myofibrils. However, binding of A6 (Fig. 1, c and d)
as well as A 1 and A5 was detectable only after treatment of
FIGURE 1 Reactivity of monoclonal antibodies B5 and A6 with
glycerinated myofibrils with and without SDS treatment detected
by indirect immunofluoréscence. B5 binding is localized in the M-
line region (arrow) of both native myofibrils (a) and SDS-treated
myofibrils (b) . A6 does not bind to native myofibrils (c), whereas M-
line fluorescence is detectable after SDS treatment (d) . Phase-
contrast (top) and fluorescence (bottom) images are paired . Bar, 5
tam . X 1,900 .
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519FIGURE 2 Immunoblots
of monoclonal an-
tibodies B5 and A6
with myofibril extracts .
Glycerinated myofibrils
were extracted with 5
mM Tris, 1 mM DTT,
pH 7 .7, for 1 or 24 h
and 25 ul of each ex-
tract was resolved by
7% SDS PAGE . Lanes 1,
3, and 5 contain 1-h ex-
tracts ; lanes 2, 4, and 6
contain 24-h extracts .
Silver stain of 1- and 24-
h extracts are shown in
lanes 1 and 2, respec-
tively. Extracts in dupli-
cate gels were electro-
phoretically transferred
to nitrocellulose mem-
brane and reacted with
B5 (lanes 3 and 4) and
A6 (lanes 5 and 6) .
Standards for molecular weight estimations included fibronectin
(230- and 220-kd subunits) glycogen debranching enzyme (165 kd),
phosphorylase b (94 kd), BSA (57 kd), and ovalbumin (45 kd) . The
apparent molecular weights of the proteins reacting with mAbs are
185,000 (lanes 3 and 4) and 165,000 (lanes 5 and 6) .
the myofibrils with 0.1% SDS . It is possible that SDS treat-
ment affects the conformation of the antigen or the accessi-
bility of the antigenic determinant within the structure of the
myofibril . Since SDS treatment did not affect the binding of
mAbs that recognize antigenic determinants in native myofi-
brils (B5 in Fig . 1 b), subsequent immunocytological locali-
zation experiments were performed on SDS-treated myofi-
brils .
The molecular specificity of binding was demonstrated on
immunoblots of myofibril extracts . Extracts were prepared by
suspending isolated myofibrils in low ionic strength buffer (5
mM Tris, 1 mM DTT, pH 7.7) (18) for 1 h or 24 h and the
extracted proteins were resolved by 7% SDS PAGE. In Fig.
2, lanes 1, 3, and 5 contain I -h extracts and lanes 2, 4, and 6
contain 24-h extracts. Fig. 2, lanes 1 and 2, demonstrate the
silverstain pattern oftotal extracted protein. Proteins resolved
on duplicate gels were electrophoretically transferred to nitro-
cellulose membranes and reacted with mAbs. Two patterns
of staining emerged . One group ofmAbs (A1, A5, A6, and
C2) represented here by A6 binds to the 165-kd protein (Fig .
2, lanes 5 and 6) which has been previously localized in the
M line (3, 16-18, 31). However, another group ofmAbs (A2,
B4, B5) represented here by B5 reacts with a distinct band of
185-kd (Fig . 2, lanes 3 and 4) . Based on immunofluorescence
localization of this group of mAbs within the myofibril (B5
shown in Fig . 1, a and b), the 185-kd protein appears to be
an M-line component that has not been previously identified.
Both proteins are released in increasing amounts up to 24 h
of myofibril extraction ; however, the relative intensities ofthe
silver-stained bands (Fig . 2, lanes 1 and 2) indicate that less
of the 185-kd protein is present compared with the 165-kd
protein . While this difference could represent quantitative
differences in myofibril content, it could also be due to
differential extraction properties of the two proteins .
Differentially extracted myofibrils from the experiment
shown in Fig. 2 were assayed for the presence ofthe 185- and
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165-kd proteins by indirect immunofluorescence . After I h
(data not shown) and to a greater extent after 24 h of extrac-
tion (Fig. 3), a reduced intensity of M-line fluorescence was
observed with both mAb B5 against the 185-kd protein (Fig.
3b) and mAb A6 against the 165-kd protein (Fig . 3d). The
binding patterns of mAbs B5 and A6 to extracted myofibrils
provides additional evidence for the specific extraction of the
185- and 165-kd proteins, respectively, from theM line.
Since there was considerable evidence from immunoblot-
ting experiments that our original immunogen contained two
distinct M-line proteins of 185 and 165 kd, we attempted to
separate and purify these two proteins . Owing to the suscep-
tibility ofmyofibrillar proteins to degradation by endogenous
proteases (3, 7, 17, 21, 32-35) the purification procedure was
repeated with the following additional precautions. Protease
inhibitors TPCK,TLCK, andPMSF (see Materials and Meth-
ods) were added to the initial homogenization and wash buffer
containing 0.5% Triton X-100 . Purification was performed
in the presence of PMSF according to the procedure of
Eppenberger and Strehler (22) with the modifications indi-
cated in Materials and Methods . The resulting elution profile
of the DEAE cellulose (DE 52, Whatman Ltd., Maidstone,
England) column is shown in Fig . 4 . Coomassie Blue-stained
7% SDS gels of corresponding fractions are inserted above
the elution profile. Two proteins, most likely glycogen de-
branching enzyme (165 kd) and phosphorylase b (94 kd) (17,
36), are eluted in fractions 62-72 and 80-137, respectively .
In contrast to previous purifications where only one additional
broad peak could be resolved, two peaks appear around
fraction 96 and fraction 113. The first of the two peaks
contains the 185-kd protein as well as several proteins with
slightly lower molecular weights as shown in the gel patterns .
The second peak contains the 165-kd M-line protein as well
FIGURE 3 Reactivity of mAb B5 against the 185-kd protein and
mAb A6 against the 165-kd protein with nonextracted (left) and
extracted (right) glycerinated myofibrils detected by indirect im-
munofluorescence . B5 was reacted with isolated control myofibrils
in solution A (a) and 24-h extracted myofibrils from experiment in
Fig . 2 (b) . A6 was reacted with control myofibrils (c) and 24-h
extracted myofibrils (d) . Paired photographs are phase contrast (top)
and fluorescence (bottom) . All myofibrils were SDS treated prior to
reaction with mAbs . Bar, 10 um . x 600 .FIGURE 4 DE 52 column chromatography profile of high salt extract of pectoralis muscle . Actomyosin was removed from a
crude high salt extract by precipitation under low salt conditions (see Materials and Methods) and the remaining extract was
eluted from a DE 52 column with a linear KCI gradient (0-0 .3 M KCI) . Insets are 7% SDS polyacrylamide gels of aliquots from
corresponding column fractions stained with Coomassie Blue . Arrows to the right indicate positions of 185-, 165-, and 94-kd
protein bands . The first minor peaks contain debranching enzyme (165 kd) followed by phosphorylase b (94 kd) which persists
in its inactive form throughout the remainder of the fractions . The two major peaks contain the 185-kd protein and the 165-kd
protein, respectively . Fractions 89-101 (1) and 102-128 (11) were pooled and phosphorylase bwas removed by Sepharose-AMP
column chromatography .
as the 94-kd phosphorylase b . These two peaks were pooled
separately as fractions I and II and the phosphorylase b was
removed by adsorption to a Sepharose-AMP column .
The selective specificity of the mAbs for one or the other
of these two fractions was demonstrated in an ELISA assay
using both fraction I and fraction II as target antigens (Table
I). The ratios of fraction II to fraction I binding indicate that
one group ofmAbs (B2, B4, and 115) preferentially binds to
fraction I containing the 185-kd and the other high molecular
weight bands, while a second group (A1, A5, and C2) includ-
ing A6 (Fig. 2) binds predominantly to fraction II that con-
tains primarily the 165-kd protein . The small amount of
binding obtained with the alternate target antigen is due to
slight cross-contamination of the two fractions. From these
data and the differential staining patterns obtained in immu-
noblotting experiments, we infer the existence of two M-line
proteins with distinct biochemical and immunological prop-
erties.
To further characterize the two M-line protein species, the
susceptibility of both the 185- and 165-kd proteins to prote-
olysis by endogenous protease is illustrated in Fig. 5 . Myofi-
brils were extracted for 24 h (Materials and Methods; Fig . 2)
and extracts were kept at 4°C for an additional 24 h . Proteins
ELISA Assay for Reactivity of Monoclonal Antibodies with M-
line Protein Fractons Iand 11
" Pooled fractions described in Fig . 4 .
TABLE I
Pooled fractions from
from the extract were resolved on 7% SDS polyacrylamide
gels, transferred to nitrocellulose, and reacted with mAbs. Fig.
5, lanes 1 and 2 (in duplicate)show the reaction of 135, a mAb
that recognizes the 185-kd protein, with the myofibril extract.
In addition to the 185-kd band, 135 stains several bands
between 185 and 165 kd that are also detected in fraction I
from the DE 52 column (Fig. 4) plus a band immediately
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Monoclonal
antibody
DE
I
52 column`
II
Ratio of reactiv-
ities II/I
A,W
A2 0.42 0.03 0.07
B4 0.72 0.13 0.18
B5 1 .22 0.44 0.36
Al 0.25 0.99 3 .9
A5 0.47 1 .19 2.7
C2 0.14 0.95 6 .9below the 165-kd band . Fig. 5, lanes 3 and 4 (in duplicate)
show the reaction of A6, a mAb that recognizes the 165-kd
protein . A6 detects a series of bands of molecular weight
< 165,000 as well as a band ofconsiderably higher molecular
weight . This higher molecular weight band has been seen
previously (17) and is thought to be an aggregate. The bands
toward the bottom of the blot probably represent small mo-
lecular weight degradation products that are not well resolved.
The distinctive patterns of degradation products obtained in
this analysis are further evidence that the 185- and 165-kd
bands represent different molecular entities. The lack ofdeg-
radation in the initial low ionic strength extracts (Fig. 2) may
have been due to prior storage of the stretched muscle fibers
in solution A containing 50% glycerol which has been re-
ported to inhibit endogenous protease activity (21). However,
prolonged maintenance at 4°C resulted in considerable deg-
radation .
The next step in the characterization of the two high
molecular weight M-line proteins was to determine howmany
antigenic determinants on each of the proteins were detected
by the mAbs . To this end, competitive binding experiments
were performed by adding each of the "S-labeled mAbs in
the presence of increasing concentrations of unlabeled mAb
to a target containing both the 185- and 165-kd proteins . Fig.
6 shows representative competition curves for one of the
mAbs against each of the M-line proteins. In Figure 6A,
unlabeled B5 displaces 91% of the binding of "S-labeled B5
to the 185-kd protein. Neither the other mAbs against the
185-kd protein (A2 and B4) nor the mAbs against the 165-kd
protein (A5 and A6) or NS-1 culture supernatant used here
FIGURE 5
￿
Proteolytic patterns of 185- and 165-kd M-line proteins .
Myofibril extracts prepared from glycerinated myofibrils by the
same procedure as those in Fig . 2 were kept at 4°C for 24 h .
Approximately 45 wg of myofibril extract in 4x sample buffer was
loaded in each lane . After 7% SDS PAGE and transfer to nitrocel-
lulose membranes, the extracts in lanes 1 and 2 were immunoblot-
ted with mAb 135 against the 185-kd protein . Duplicate extracts in
lanes 3 and 4 were immunoblotted with mAb A6 against the 165-
kd protein . Apparent molecular weights were determined as in Fig .
2 .
522
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 98, 1984
as negative controls demonstrated significant competition .
This result indicates that B5 recognizes a unique antigenic
determinant on the 185-kd molecule. Similar results were
obtained for the other mAbs against the 185-kd protein (A2
and B4), indicating the presence of two additional unique
antigenic determinants characterized by A2 and B4 .
Similar experiments were carried out for mAbs recognizing
the 165-kd antigen . The competition for "S-labeled A6 bind-
ing is shown in Fig . 6B. Both unlabeled A6 and A1 compete
with 15S-labeled A6 for binding to the 165-kd protein, al-
though A1 competes to a lesser extent (44% compared with
87% for A6) . This discrepancy in maximum competition for
binding could be due to a lower binding affinity for A 1 since
in the reciprocal competition experiment unlabeled A6 com-
petes with "S-labeled A 1 equally as well as unlabeled A 1
(98% compared with 85%, respectively) with similar compet-
itive binding curves . While it is apparent that neither the other
mAbs against the 165-kd protein (A5 and C2) nor the negative
controls(mAb B4 against the 185-kd protein and NS-1 culture
supernatant) compete specifically for "S-labeled A6 binding,
the slight slope ofthe curves for these unlabeled antibodies at
the highest concentration suggests nonspecific interference of
binding. In competitive binding experiments with the other
mAbs against the 165-kd protein, A5 andC2 also demonstrate
competitive inhibition of binding. The inhibition of "S-la-
beled mAb binding by negative controls is most evident when
the maximum binding of labeled mAb in the absence of
unlabeled competitors falls below 600 dpm, suggesting that
the mAbs with lower binding affinities are more sensitive to
nonspecific binding interference.
Table II summarizes the results ofthe competitive binding
experiments for all the mAbs against both M-line proteins .
All the mAbs against the 185-kd protein recognize distinct
determinants, while 2 sets of mAbs (A5 and C2, A6 and A1)
against the 165-kd protein demonstrate competitive binding
suggesting identical or overlapping antigenic determinants or
steric hindrance of binding. The finding that C2 binds to
native myofibrils while A5 binds only to SDS-treated myofi-
brils, in addition to the evidence that A5 and A6, but notC2
or A1, bind to myofibrils from muscles of other species (Dr .
Monika Eppenberger, this laboratory, personal communica-
tion), suggests that the antigenic determinants for these two
sets ofmAbs are not identical . Thus we have produced mAbs
against three antigenic determinants on the 185-kd M-line
protein as well as mAbs against at least two and probably
against four determinants on the 165-kd M-line protein.
DISCUSSION
Biochemical characterization of high molecular weight M-
line proteins has been fraught with difficulties owing to con-
tamination and degradation of the proteins during purifica-
tion (7, 16-18) . Polyclonal antibodies were raised against the
most purified high molecular weight M-line protein fraction
(165 kd) and these antibodies also reflected the heterogeneous
nature ofthe proteins in this purified fraction but were unable
to discriminate between 165-kd degradation products and the
presence ofadditional proteins . These problems were circum-
ventedbygeneratingmAbs directed against the M-line protein
fraction .
We have obtained mAbs that recognize two distinct M-line
proteins with molecular weights of 165,000 and 185,000. The
characterization of these mAbs indicates that all the mAbs
recognize unique or, in two instances, possibly overlappingO
E
a
ß
Z
O
m
Q
E
N
in
* ND, not determined.
FIGURE 6
￿
Competitive binding curves for the mAb B5 against the 185-kd protein (A) and mAb A6 against the 165-kd protein (8).
(A) 'SS-labeled B5 (18,000 dpm/well) binding in the presence of increasing concentrations of B5 (0), A6 (O), B4 (/), NS-1
supernatant (x), A5 (p), or A2 (A). The target antigen was purified fraction I at 1 Fig/well . (8) 35S-labeled A6 (17,000 dpm/well)
binding in the presence of increasing concentrations of A6 (O), Al (A), B4 (E), NS-1 supernatant (x), C2 ((D), or A5 (p). The
original 165-kd immunogen, which also contained the 185-kd protein, was used as the target antigen at 1 Ag/ml. In both
experiments antibodies were reacted with the targets for 3 h. The bound radioactivity was solubilized in 100 juI of 2 N NaOH
and counted. Background values obtained from wells not coated with target were subtracted from the experimental values.
UNLABELED mAb, PI
￿
UNLABELED mAb, PI
antigenic determinants and that none of the mAbs reacting
with the 185-kd protein demonstrates cross-reactivity with
the 165-kd species and vice versa. The 165-kd M-line protein
has been previously purified and characterized (3, 17, 22).
While other high molecular weight myofibrillar proteins have
been reported (21, 37), their localization could only be in-
ferred by circumstantial evidence. The finding of the 185-kd
protein reported here is to our knowledge the first concrete
evidence for a second high molecular weight Wine protein.
Inability to detect the 185-kd protein in previous purifications
1.25
1.00
0.75
0.50
0.25
C2
ofthe 165-kd protein may have been due to the small quantity
of this protein present in myofibrils relative to the 165-kd
protein, degradation, poor resolution on overloaded polyac-
rylamide gels, or a combination of these effects.
Polyclonal antibodies raised in rabbits against a chicken
165-kd M-line protein fraction were used to detect the ap-
pearance ofM linesduring myofibrillogenesis in cultured cells
(31) and were shown to react specifically with skeletal muscle
and heart in a variety of species (31, 38). In immunoblot
experiments, these polyclonal antibodies detect all the bands
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Specificity
TABLE II
of Monoclonal Antibodies for Antigenic Determinants
'SS-labeled mAbs
Anti-185-kd protein Anti-165-kd protein
Unlabeled mAbs A2 B4 B5 Al A6 A5
Anti-185-kd protein A2 + ND* ND
B4
B5 + - ND ND
Anti-165-kd protein Al ND + + -
A6
A5
C2 ND ND ND - - +
Control NS-1recognized by mAbs against both the 165- and the 185-kd
protein. Work in progress using the mAbs described here
indicates that the protein that had been detected by the
polyclonal antibodies in short-term cell cultures (31) and in
early chick embryos (39) is most likely the 185-kd M-line
protein and not the 165-kd protein as previously believed.
Since myomesin was the name given to the M-line protein
appearing early in myogenesis(31), we propose, in agreement
with Dr. T. Masaki (U. of Tsukuba, Japan, personal com-
munication), that "myomesin" be used to designate the 185-
kd M-line protein. The 165-kd protein will continue to be
called "M-protein" (3).
The inability of the polyclonal antibodies to clearly define
the localization of the 165-kd protein within the M line (19)
may be due to the heterogeneity of these polyclonal anti-
bodies. Experiments are now in progress to determine the
substructural localization of both the 185-kd myomesin and
the 165-kd M protein within the M line using mAbs. The
selective mAb probes will also be used to better define and
extend the initial findings on the developmental regulation of
these two proteins during myogenesis in vivo and in cell
culture.
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